These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 14221802

  • 21. CHEMOTHERAPEUTIC EFFECTS ON MAMMALIAN TUMOR CELLS. I. MODIFICATION OF LEUKEMIA L1210 GROWTH KINETICS AND KARYOTYPE WITH AN ALKYLATING AGENT.
    JOHNSON RE, ZELEN M, KEMP NH.
    J Natl Cancer Inst; 1965 Feb; 34():277-90. PubMed ID: 14293793
    [No Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA, Sirotnak FM, Otter GM, DeGraw JI.
    Cancer Treat Rep; 1987 Feb; 71(7-8):727-32. PubMed ID: 3607784
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR, Atkins LM, Meischen SJ, Smith AB, Walker EM.
    Cancer Treat Rep; 1977 Feb; 61(3):445-50. PubMed ID: 872142
    [Abstract] [Full Text] [Related]

  • 24. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D, Hilliard SL.
    Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
    [No Abstract] [Full Text] [Related]

  • 25. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I, Venditti JM, Mead JA, Tyrer DD, Goldin A.
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract] [Full Text] [Related]

  • 26. ACTIVITY OF SELECTED COMPOUNDS IN SUBLINE OF LEUKEMIA L1210 RESISTANT TO CYTOSINE ARABINOSIDE (NSC-63878).
    WODINSKY I, KENSLER CJ.
    Cancer Chemother Rep; 1964 Dec; 43():1-3. PubMed ID: 14250647
    [No Abstract] [Full Text] [Related]

  • 27. EFFECTS OF OTHER AGENTS ON THE BIOLOGIC RESPONSES TO VINCALEUKOBLASTINE.
    CUTTS JH.
    Biochem Pharmacol; 1964 Mar; 13():421-31. PubMed ID: 14157604
    [No Abstract] [Full Text] [Related]

  • 28. Effectiveness of 2-chloro-4',4"-di-2-imidazolin-2-ylterephthal-anilide and methotrexate, in combination, against advanced leukemia L1210.
    VENDITTI JM, GOLDIN A, KLINE I.
    Cancer Res; 1963 May; 23():593-9. PubMed ID: 13996649
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. HYDROXYMETHYLGLYOXAL BISGUANYLHYDRAZONE.
    LOO TL, DION RL, DAVIDSON JD, ADAMSON RH.
    J Med Chem; 1963 Nov; 6():819-20. PubMed ID: 14184964
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XV.
    LEITER J, ABBOTT BJ, BOURKE AR, SCHEPARTZ SA, WODINSKY I.
    Cancer Res; 1963 Sep; 23():SUPPL1483-729. PubMed ID: 14070401
    [No Abstract] [Full Text] [Related]

  • 34. Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
    Straus MJ, Goldin A.
    Cancer Chemother Rep; 1972 Feb; 56(1):19-23. PubMed ID: 5030804
    [No Abstract] [Full Text] [Related]

  • 35. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XVI.
    LEITER J, ABBOTT BJ, BOURKE AR, SCHEPARTZ SA, WODINSKY I.
    Can Res Suppl; 1963 Nov; ():1930-2033. PubMed ID: 14085011
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA, Hutchison DJ.
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    VENDITTI JM, SCHRECKER AW, MEAD JA, KLINE I, GOLDIN A.
    Cancer Res; 1960 Nov; 20():1451-6. PubMed ID: 13780697
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.